Clinical trial
The Influence of Residual Beta Cell Function on Hypoglycaemia Risk and Treatment Response in Type 2 Diabetes
NCT02506296 is registered in ClinicalTrials.gov with Royal Devon and Exeter NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Influence of Residual Beta Cell Function on Hypoglycaemia Risk and Treatment Response in Type 2 Diabetes
- Lead sponsor
- Royal Devon and Exeter NHS Foundation Trust
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- November 30, 2015
- Enrollment
- 53 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes